🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation ◆ Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand ◆ A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation ◆ Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand ◆
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Cipla Europe NV — Licensed Medicines

6 medicines held by Cipla Europe NV on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 6 products held by Cipla Europe NV
MedicineActive substanceLicence holderStatus
Fexofast 120 mg Film-coated Tablets
PA1963/014/001
 Fexofenadine hydrochloride Cipla Europe NV Not marketed
Fexofast 180 mg Film-coated Tablets
PA1963/014/002
 Fexofenadine hydrochloride Cipla Europe NV Not marketed
Sereflo 25 microgram/125 microgram per actuation pressurised inhalation, suspension
PA1963/013/001
 Fluticasone propionate, Salmeterol Cipla Europe NV Not marketed
Sereflo 25 microgram/250 microgram per actuation pressurised inhalation, suspension
PA1963/013/002
 Fluticasone propionate, Salmeterol Cipla Europe NV Not marketed
Zoreeda 25 microgram/125 microgram per actuation pressurised inhalation, suspension
PA1963/009/001
 Fluticasone propionate, Salmeterol Cipla Europe NV Not marketed
Zoreeda 25 microgram/250 microgram per actuation pressurised inhalation, suspension
PA1963/009/002
 Fluticasone propionate, Salmeterol Cipla Europe NV Not marketed
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.